Lantheus (NASDAQ:LNTH – Get Free Report) had its target price lowered by stock analysts at JMP Securities from $130.00 to $100.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm presently has a “market outperform” rating on the medical equipment provider’s stock. JMP Securities’ price objective indicates a potential […]